{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:12:16Z","timestamp":1793121136416,"version":"4.5.0"},"reference-count":59,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thrombotic microangiopathy and acute renal failure are cardinal features of postdiarrheal hemolytic uremic syndrome (HUS). These conditions are related to endothelial and epithelial cell damage induced by Shiga toxin (Stx) through the interaction with its globotriaosyl ceramide receptor. However, inflammatory processes contribute to the pathogenesis of HUS by sensitizing cells to Stx fractalkine (FKN), a CX3C transmembrane chemokine expressed on epithelial and endothelial cells upon activation, is involved in the selective migration and adhesion of specific leukocyte subsets to tissues. Here, we demonstrated a selective depletion of circulating mononuclear leukocytes expressing the receptor for FKN (CX3CR1) in patients with HUS. We found a unique phenotype in children with HUS distinct from that seen in healthy, uremic, or infected controls, in which monocytes lost CX3CR1, down-modulated CD62L, and increased CD16. In addition, the CD56dim natural killer (NK) subpopulation was decreased, leading to an altered peripheral CD56dim\/CD56bright ratio from 10.0 to 4.5. It is noteworthy that a negative correlation existed between the percentage of circulating CX3CR1+ leukocytes and the severity of renal failure. Finally, CX3CR1+ leukocytes were observed in renal biopsies from patients with HUS. We suggest that the interaction of CX3CR1+ cells with FKN present on activated endothelial cells may contribute to renal injury in HUS.<\/jats:p>","DOI":"10.1182\/blood-2006-06-026997","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T03:14:03Z","timestamp":1164770043000},"page":"2438-2445","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":33,"title":["Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome"],"prefix":"10.1182","volume":"109","author":[{"given":"Mari\u0301a Victoria","family":"Ramos","sequence":"first","affiliation":[{"name":"Division of Immunology, Institute of Hematological Investigations, Academia Nacional de Medicina, Buenos Aires, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela C.","family":"Ferna\u0301ndez","sequence":"additional","affiliation":[{"name":"Division of Immunology, Institute of Hematological Investigations, Academia Nacional de Medicina, Buenos Aires, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Patey","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Pathology, Ho\u0302pital Necker Enfants-Malades, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Schierloh","sequence":"additional","affiliation":[{"name":"Division of Immunology, Institute of Hematological Investigations, Academia Nacional de Medicina, Buenos Aires, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramo\u0301n","family":"Exeni","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Municipal del Nin\u0303o, San Justo, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Grimoldi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Municipal del Nin\u0303o, San Justo, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Vallejo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital de Nin\u0303os \u201cRicardo Gutie\u0301rrez,\u201d Buenos Aires, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Eli\u0301as-Costa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital de Nin\u0303os \u201cRicardo Gutie\u0301rrez,\u201d Buenos Aires, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"del Carmen Sasiain","sequence":"additional","affiliation":[{"name":"Division of Immunology, Institute of Hematological Investigations, Academia Nacional de Medicina, Buenos Aires, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Trachtman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Nephrology, Schneider Children's Hospital, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Combadie\u0300re","sequence":"additional","affiliation":[{"name":"INSERM (Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale) U543, Universite\u0301 Pierre et Marie Curie, Ho\u0302pital Pitie\u0301-Salpe\u0301trie\u0300re, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc\u0327ois","family":"Proulx","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Intensive Care, Ste-Justine Hospital, Montreal, QC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina S.","family":"Palermo","sequence":"additional","affiliation":[{"name":"Division of Immunology, Institute of Hematological Investigations, Academia Nacional de Medicina, Buenos Aires, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2006,11,28]]},"reference":[{"key":"2019111711580102900_B1","doi-asserted-by":"crossref","unstructured":"Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis1985; 151:775\u2013782.","DOI":"10.1093\/infdis\/151.5.775"},{"key":"2019111711580102900_B2","doi-asserted-by":"crossref","unstructured":"Remuzzi G and Ruggenenti P. The hemolytic uremic syndrome. Kidney Int1995; 48:2\u201319.","DOI":"10.1038\/ki.1995.261"},{"key":"2019111711580102900_B3","doi-asserted-by":"crossref","unstructured":"Paton JC and Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev1998; 11:450\u2013479.","DOI":"10.1128\/CMR.11.3.450"},{"key":"2019111711580102900_B4","unstructured":"Keusch GT and Acheson DW. Thrombotic thrombocytopenic purpura associated with Shiga toxins. Semin Hematol1997; 34:106\u2013116."},{"key":"2019111711580102900_B5","doi-asserted-by":"crossref","unstructured":"Stahl AL, Svensson M, Morgelin M, et al. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets via TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood2006; 108:167\u2013176.","DOI":"10.1182\/blood-2005-08-3219"},{"key":"2019111711580102900_B6","doi-asserted-by":"crossref","unstructured":"Harrison LM, van den Hoogen C, van Haaften WC, Tesh VL. Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and\/or lipopolysaccharides. Infect Immun2005; 73:403\u2013412.","DOI":"10.1128\/IAI.73.1.403-412.2005"},{"key":"2019111711580102900_B7","doi-asserted-by":"crossref","unstructured":"Guessous F, Marcinkiewicz M, Polanowska-Grabowska R, Keepers TR, Obrig T, Gear AR. Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function. Thromb Haemost2005; 94:1019\u20131027.","DOI":"10.1160\/TH05-02-0115"},{"key":"2019111711580102900_B8","doi-asserted-by":"crossref","unstructured":"Proulx F, Toledano B, Phan V, Clermont MJ, Mariscalco MM, Seidman EG. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome. Pediatr Res2002; 52:928\u2013934.","DOI":"10.1203\/00006450-200212000-00019"},{"key":"2019111711580102900_B9","doi-asserted-by":"crossref","unstructured":"Palermo MS, Alves Rosa MF, Van Rooijen N, Isturiz MA. Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model. Clin Exp Immunol1999; 116:462\u2013467.","DOI":"10.1046\/j.1365-2249.1999.00925.x"},{"key":"2019111711580102900_B10","doi-asserted-by":"crossref","unstructured":"Meerschaert J and Furie MB. The adhesion molecules used by monocytes for migration across endothelium include CD11a\/CD18, CD11b\/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium. J Immunol1995; 154:4099\u20134112.","DOI":"10.4049\/jimmunol.154.8.4099"},{"key":"2019111711580102900_B11","doi-asserted-by":"crossref","unstructured":"Patarroyo M. Adhesion molecules mediating recruitment of monocytes to inflamed tissue. Immunobiology1994; 191:474\u2013477.","DOI":"10.1016\/S0171-2985(11)80453-5"},{"key":"2019111711580102900_B12","doi-asserted-by":"crossref","unstructured":"Umehara H, Bloom ET, Okazaki T, Nagano Y, Yoshie O, Imai T. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol2004; 24:34\u201340.","DOI":"10.1161\/01.ATV.0000095360.62479.1F"},{"key":"2019111711580102900_B13","doi-asserted-by":"crossref","unstructured":"Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature1997; 385:640\u2013644.","DOI":"10.1038\/385640a0"},{"key":"2019111711580102900_B14","doi-asserted-by":"crossref","unstructured":"Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell1997; 91:521\u2013530.","DOI":"10.1016\/S0092-8674(00)80438-9"},{"key":"2019111711580102900_B15","doi-asserted-by":"crossref","unstructured":"Fong AM, Robinson LA, Steeber DA, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med1998; 188:1413\u20131419.","DOI":"10.1084\/jem.188.8.1413"},{"key":"2019111711580102900_B16","doi-asserted-by":"crossref","unstructured":"Beck GC, Yard BA, Breedijk AJ, Van Ackern K, Van Der Woude FJ. Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells. Clin Exp Immunol1999; 118:298\u2013303.","DOI":"10.1046\/j.1365-2249.1999.01052.x"},{"key":"2019111711580102900_B17","doi-asserted-by":"crossref","unstructured":"Chakravorty SJ, Cockwell P, Girdlestone J, Brooks CJ, Savage CO. Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion. Clin Exp Immunol2002; 129:150\u2013159.","DOI":"10.1046\/j.1365-2249.2002.01906.x"},{"key":"2019111711580102900_B18","doi-asserted-by":"crossref","unstructured":"Muehlhoefer A, Saubermann LJ, Gu X, et al. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal. mucosa. J Immunol2000; 164:3368\u20133376.","DOI":"10.4049\/jimmunol.164.6.3368"},{"key":"2019111711580102900_B19","doi-asserted-by":"crossref","unstructured":"Umehara H, Bloom E, Okazaki T, Domae N, Imai T. Fractalkine and vascular injury. Trends Immunol2001; 22:602\u2013607.","DOI":"10.1016\/S1471-4906(01)02051-8"},{"key":"2019111711580102900_B20","doi-asserted-by":"crossref","unstructured":"Yoneda O, Imai T, Nishimura M, et al. Membrane-bound form of fractalkine induces IFN-gamma production by NK cells. Eur J Immunol2003; 33:53\u201358.","DOI":"10.1002\/immu.200390007"},{"key":"2019111711580102900_B21","doi-asserted-by":"crossref","unstructured":"Papadopoulos EJ, Sassetti C, Saeki H, et al. Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol1999; 29:2551\u20132559.","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO;2-T"},{"key":"2019111711580102900_B22","doi-asserted-by":"crossref","unstructured":"Dichmann S, Herouy Y, Purlis D, Rheinen H, Gebicke-Harter P, Norgauer J. Fractalkine induces chemotaxis and actin polymerization in human dendritic cells. Inflamm Res2001; 50:529\u2013533.","DOI":"10.1007\/PL00000230"},{"key":"2019111711580102900_B23","doi-asserted-by":"crossref","unstructured":"Haskell CA, Cleary MD, Charo IF. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J Biol Chem1999; 274:10053\u201310058.","DOI":"10.1074\/jbc.274.15.10053"},{"key":"2019111711580102900_B24","doi-asserted-by":"crossref","unstructured":"Goda S, Imai T, Yoshie O, et al. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J Immunol2000; 164:4313\u20134320.","DOI":"10.4049\/jimmunol.164.8.4313"},{"key":"2019111711580102900_B25","doi-asserted-by":"crossref","unstructured":"Feng L, Chen S, Garcia GE, et al. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int1999; 56:612\u2013620.","DOI":"10.1046\/j.1523-1755.1999.00604.x"},{"key":"2019111711580102900_B26","doi-asserted-by":"crossref","unstructured":"Chen S, Bacon KB, Li L, et al. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med1998; 188:193\u2013198.","DOI":"10.1084\/jem.188.1.193"},{"key":"2019111711580102900_B27","doi-asserted-by":"crossref","unstructured":"Segerer S, Hughes E, Hudkins KL, Mack M, Goodpaster T, Alpers CE. Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney Int2002; 62:488\u2013495.","DOI":"10.1046\/j.1523-1755.2002.00480.x"},{"key":"2019111711580102900_B28","doi-asserted-by":"crossref","unstructured":"Ito Y, Kawachi H, Morioka Y, et al. Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis. Kidney Int2002; 61:2044\u20132057.","DOI":"10.1046\/j.1523-1755.2002.00369.x"},{"key":"2019111711580102900_B29","unstructured":"Boyum A. Separation of leukocytes from blood and bone marrow: introduction. Scand J Clin Lab Invest Suppl1968; 97:7."},{"key":"2019111711580102900_B30","doi-asserted-by":"crossref","unstructured":"Ziegler-Heitbrock HW. Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today1996; 17:424\u2013428.","DOI":"10.1016\/0167-5699(96)10029-3"},{"key":"2019111711580102900_B31","doi-asserted-by":"crossref","unstructured":"Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity2003; 19:71\u201382.","DOI":"10.1016\/S1074-7613(03)00174-2"},{"key":"2019111711580102900_B32","doi-asserted-by":"crossref","unstructured":"Ziegler-Heitbrock HW. Definition of human blood monocytes. J Leukoc Biol2000; 67:603\u2013606.","DOI":"10.1002\/jlb.67.5.603"},{"key":"2019111711580102900_B33","doi-asserted-by":"crossref","unstructured":"Frey M, Packianathan NB, Fehniger TA, et al. Differential expression and function of L-selectin on CD56bright and CD56dim Natural Killer subsets. J Immunol1998; 161:400\u2013408.","DOI":"10.4049\/jimmunol.161.1.400"},{"key":"2019111711580102900_B34","doi-asserted-by":"crossref","unstructured":"Campbell JJ, Qin S, Unutmaz D, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol2001; 166:6477\u20136482.","DOI":"10.4049\/jimmunol.166.11.6477"},{"key":"2019111711580102900_B35","doi-asserted-by":"crossref","unstructured":"Schierloh P, Yokobori N, Aleman M, et al. Increased susceptibility to apoptosis of CD56dimCD16+ NK cells induces the enrichment of IFN-gamma-producing CD56bright cells in tuberculous pleurisy. J Immunol2005; 175:6852\u20136860.","DOI":"10.4049\/jimmunol.175.10.6852"},{"key":"2019111711580102900_B36","doi-asserted-by":"crossref","unstructured":"Gianantonio CA, Vitaco M, Mendilaharzu F, Gallo GE, Sojo ET. The hemolytic-uremic si\u0301ndrome. Nephron1973; 11:174\u2013192.","DOI":"10.1159\/000180229"},{"key":"2019111711580102900_B37","doi-asserted-by":"crossref","unstructured":"Fernandez GC, Ramos MV, Gomez SA, et al. Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome. J Leukoc Biol2005; 78:853\u2013861.","DOI":"10.1189\/jlb.0505251"},{"key":"2019111711580102900_B38","doi-asserted-by":"crossref","unstructured":"Ancuta P, Weiss L, Haeffner-Cavaillon N. CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics. Eur J Immunol2000; 30:1872\u20131883.","DOI":"10.1002\/1521-4141(200007)30:7<1872::AID-IMMU1872>3.0.CO;2-2"},{"key":"2019111711580102900_B39","doi-asserted-by":"crossref","unstructured":"Olikowsky T, Wang ZQ, Dudhane A, Horowitz H, Conti B, Hoffmann MK. Two distinct pathways of human macrophage differentiation are mediated by interferon-gamma and interleukin-10. Immunology1997; 91:104\u2013108.","DOI":"10.1046\/j.1365-2567.1997.00204.x"},{"key":"2019111711580102900_B40","doi-asserted-by":"crossref","unstructured":"Kishimoto TK, Jutila MA, Butcher EC. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc Natl Acad Sci U S A1990; 87:2244\u20132248.","DOI":"10.1073\/pnas.87.6.2244"},{"key":"2019111711580102900_B41","doi-asserted-by":"crossref","unstructured":"Tedder TF, Steeber DA, Pizcueta P. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med1995; 181:2259\u20132264.","DOI":"10.1084\/jem.181.6.2259"},{"key":"2019111711580102900_B42","doi-asserted-by":"crossref","unstructured":"Chen A, Engel P, Tedder TF. Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes. J Exp Med1995; 182:519\u2013530.","DOI":"10.1084\/jem.182.2.519"},{"key":"2019111711580102900_B43","doi-asserted-by":"crossref","unstructured":"Dadfar E, Lundahl J, Jacobson SH. Monocyte adhesion molecule expression in interstitial inflammation in patients with renal failure. Nephrol Dial Transplant2004; 19:614\u2013622.","DOI":"10.1093\/ndt\/gfg585"},{"key":"2019111711580102900_B44","doi-asserted-by":"crossref","unstructured":"Chapman GA, Moores KE, Gohil J, et al. The role of fractalkine in the recruitment of monocytes to the endothelium. Eur J Pharmacol2000; 392:189\u2013195.","DOI":"10.1016\/S0014-2999(00)00117-5"},{"key":"2019111711580102900_B45","doi-asserted-by":"crossref","unstructured":"Ancuta P, Rao R, Moses A, et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med2003; 197:1701\u20131707.","DOI":"10.1084\/jem.20022156"},{"key":"2019111711580102900_B46","doi-asserted-by":"crossref","unstructured":"Salvo G, Samoggia P, Masciulli R, et al. Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: role of cell adhesion to endothelium. Eur J Cancer1992; 28A:818\u2013825.","DOI":"10.1016\/0959-8049(92)90122-I"},{"key":"2019111711580102900_B47","doi-asserted-by":"crossref","unstructured":"Aronson FR, Libby P, Brandon EP, Janicka MW, Mier JW. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells: a potential mechanism for endothelial injury. J Immunol1988; 141:158\u2013163.","DOI":"10.4049\/jimmunol.141.1.158"},{"key":"2019111711580102900_B48","doi-asserted-by":"crossref","unstructured":"Lentsch AB, Miller FN, Edwards MJ. Mechanisms of leukocyte-mediated tissue injury induced by interleukin-2. Cancer Immunol Immunother1999; 47:243\u2013248.","DOI":"10.1007\/s002620050527"},{"key":"2019111711580102900_B49","doi-asserted-by":"crossref","unstructured":"Alexandrescu DT, Maddukuri P, Wiernik PH, Dutcher JP. Thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanoma. J Immunother2005; 28:144\u2013147.","DOI":"10.1097\/01.cji.0000154250.82007.4a"},{"key":"2019111711580102900_B50","doi-asserted-by":"crossref","unstructured":"Lanier LL. Face off: the interplay between activating and inhibitory immune receptors. Curr Opin Immunol2001; 13:326\u201331.","DOI":"10.1016\/S0952-7915(00)00222-3"},{"key":"2019111711580102900_B51","doi-asserted-by":"crossref","unstructured":"Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet2005; 365:1073\u20131086.","DOI":"10.1016\/S0140-6736(05)74232-X"},{"key":"2019111711580102900_B52","doi-asserted-by":"crossref","unstructured":"Chandler WL, Jelacic S, Boster DR, et al. Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med2002; 346:23\u201332.","DOI":"10.1056\/NEJMoa011033"},{"key":"2019111711580102900_B53","doi-asserted-by":"crossref","unstructured":"Harrison JK, Jiang Y, Wees EA, et al. Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart. J Leukoc Biol1999; 66:937\u2013944.","DOI":"10.1002\/jlb.66.6.937"},{"key":"2019111711580102900_B54","doi-asserted-by":"crossref","unstructured":"Imaizumi T, Yoshida H, Satoh K. Regulation of CX3CL1\/fractalkine expression in endothelial. cells. J Atheroscler Thromb2004; 11:15\u201321.","DOI":"10.5551\/jat.11.15"},{"key":"2019111711580102900_B55","doi-asserted-by":"crossref","unstructured":"Litalien C, Proulx F, Mariscalco MM, et al. Circulating inflammatory cytokine levels predict severity of renal failure in hemolytic uremic syndrome. Pediatr Nephrol1999; 13:840\u2013845.","DOI":"10.1007\/s004670050712"},{"key":"2019111711580102900_B56","doi-asserted-by":"crossref","unstructured":"Westerholt S, Pieper AK, Griebel M, Volk HD, Hartung T, Oberhoffer R. Characterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome. Clin Diagn Lab Immunol2003; 10:1090\u20131095.","DOI":"10.1128\/CDLI.10.6.1090-1095.2003"},{"key":"2019111711580102900_B57","doi-asserted-by":"crossref","unstructured":"Fraticelli P, Sironi M, Bianchi G, et al. Fractalkine (CX3CR1) as an amplification circuit of polarized Th1 responses. J. Clin Invest2001; 107:1173\u20131181.","DOI":"10.1172\/JCI11517"},{"key":"2019111711580102900_B58","doi-asserted-by":"crossref","unstructured":"Barlic J, Sechler JM, Murphy PM. IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1. Blood2003; 102:3494\u20133503.","DOI":"10.1182\/blood-2003-03-0946"},{"key":"2019111711580102900_B59","doi-asserted-by":"crossref","unstructured":"Infante-Duarte C, Weber A, Kratzschmar J, et al. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients. FASEB J2005; 19:1902\u20131904.","DOI":"10.1096\/fj.05-3832fje"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/6\/2438\/1477986\/zh800607002438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/6\/2438\/1477986\/zh800607002438.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T21:12:01Z","timestamp":1683666721000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/109\/6\/2438\/23308\/Involvement-of-the-fractalkine-pathway-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,28]]},"references-count":59,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,11,28]]},"published-print":{"date-parts":[[2007,3,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-06-026997","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,28]]}}}